Last reviewed · How we verify
NCT03410940
PMCF Study of the CLS Brevius Stem With Kinectiv Technology
trial testing CLS Brevius stem with Kinectiv technology in Osteoarthritis in 223 participants. Terminated before completion.
8 April 2019
Quick facts
| Lead sponsor | Zimmer Biomet |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 223 |
| Start date | 7 January 2011 |
| Primary completion | 8 April 2019 |
| Estimated completion | 14 December 2020 |
| Sites | 4 locations across Italy, Spain, Poland |
Drugs / interventions tested
- CLS Brevius stem with Kinectiv technology
Conditions studied
- Osteoarthritis — all drugs for Osteoarthritis →
- Avascular Necrosis — all drugs for Avascular Necrosis →
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Femoral Neck Fractures — all drugs for Femoral Neck Fractures →
Sponsor
Zimmer Biomet — full company profile →
Who can join
18 and older, any sex, with Osteoarthritis or Avascular Necrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a multi-center, prospective, non-controlled post-market surveillance study. The primary objective of this study is to confirm the safety and performance of the CLS Brevius stem with Kinectiv technology by obtaining implant survivorship and clinical outcomes data for the commercially available stem.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Satisfactory clinical and radiologic outcomes with a new shorter and modular stem for end-stage hip osteoarthritis: an international prospective multicentre pilot study.
D'Ambrosi R, Toni A, Czubak J, Guadilla J, et al · · 2022 · cited 1× · PMID 35380533 · DOI 10.1051/sicotj/2022005
Verify or expand the search:
- PubMed search for NCT03410940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis
Currently open trials in the same condition.
- NCT07404891 — Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis · NA · recruiting
- NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
- NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
- NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
- NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting
Other Zimmer Biomet trials
Trials by the same sponsor.
- NCT06287853 — Tapestry Rotator Cuff Repair PMCF · suspended
- NCT06863428 — Mymobility Knee ROM · recruiting
- NCT06920459 — Zimmer Biomet Shoulder Arthroplasty PMCF Study · recruiting
- NCT07009912 — ROSA® Knee System V1.5 Pilot Study · NA · completed
- NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03410940 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zimmer Biomet
- Last refreshed: 17 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03410940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing